"Designing Growth Strategies is in our DNA"

U.S. C-Reactive Protein Testing Market Size, Share & COVID-19 Impact Analysis, By Product (Reagent & Kits and Instruments), By Assay Type (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunoturbidimetric Assay, and Others), By Detection Range (Conventional CRP and Hs-CRP), By Setting (Laboratory Testing, and Point-of-Care (POC) Testing), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI108429

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year 

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 5.1% from 2023 to 2030

Unit

Value (USD Million)

Segmentation

By Product

  • Reagents & Kits
  • Instruments

By Assay Type

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunoturbidimetric Assay
  • Others

By Detection Range

  • Conventional CRP
  • Hs-CRP

By Setting

  • Laboratory Testing
  • Point-of-Care (POC) Testing

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 90
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann